Lung cancer and breast cancer are the two most common causes of cancer-related fluid buildup around the lungs, together accounting for 50% to 65% of all cases. This condition, called a malignant pleural effusion, happens when cancer causes fluid to collect in the thin space between the lungs and the chest wall. Several other cancers can cause it too, and the fluid itself often signals advanced disease.
Which Cancers Cause It Most Often
In men, lung cancer is the leading cause. In women, it’s breast cancer. These two cancers dominate because they either start in or frequently spread to the chest. Lymphoma is the next most common, responsible for roughly 10% of cases. Ovarian cancer and stomach cancer each account for about 5%.
Mesothelioma deserves special mention. It’s a cancer that starts in the lining of the lungs itself, and more than 90% of people with mesothelioma develop fluid buildup. While it’s far less common than lung or breast cancer overall, it’s the single most likely cancer to produce this symptom.
How Cancer Causes Fluid to Accumulate
Your body constantly produces and reabsorbs small amounts of fluid in the space around the lungs. Cancer disrupts this balance in two main ways. First, tumor cells can block the lymphatic vessels that normally drain fluid away from the chest. When drainage slows or stops entirely, fluid backs up. Second, cancer can make the blood vessels and membranes lining the chest more “leaky,” allowing extra fluid to seep into the space faster than the body can remove it.
Sometimes both mechanisms happen at once, which is why malignant effusions can grow large quickly and return after being drained.
Symptoms to Recognize
The most common symptom is shortness of breath. The fluid compresses the lung, limits chest wall movement, and pushes down on the diaphragm, all of which make it harder to take a full breath. Many people also notice a dry cough, chest heaviness, or discomfort that worsens when lying flat. The symptoms tend to creep up gradually as fluid accumulates, so you might first notice it only during exercise before it starts affecting you at rest.
In about 30% of symptomatic cases, the lung can no longer fully re-expand even after the fluid is removed. This happens when the cancer has essentially “trapped” the lung by coating or thickening its outer surface, preventing it from inflating normally.
What It Means for Cancer Staging
For lung cancer specifically, a malignant pleural effusion automatically classifies the disease as stage IV (specifically M1a in the TNM staging system). This is true regardless of the size of the original tumor. There is one narrow exception: if repeated fluid samples show no cancer cells, the fluid isn’t bloody, and doctors determine it’s unrelated to the tumor, it can be excluded from staging. But in practice, most effusions in lung cancer patients are caused by the cancer.
For other cancers like breast or ovarian, a malignant pleural effusion similarly indicates the disease has spread beyond its original site.
How Fluid Is Diagnosed
Doctors typically use ultrasound to guide a needle into the fluid space and withdraw a sample for testing. A pathologist then examines the fluid under a microscope looking for cancer cells. This test catches cancer about 58% of the time overall, but accuracy varies enormously depending on the cancer type.
Lung adenocarcinoma (the most common type of lung cancer) has a detection rate of about 84%, and ovarian cancer is similarly high at 85%. Squamous cell lung cancer is much harder to spot in fluid, with a detection rate of only 24%. Mesothelioma is also difficult at 29%. So a negative fluid test doesn’t rule out cancer. If suspicion remains, doctors will typically pursue additional tissue sampling.
Treatment Options for Recurrent Fluid
If you’re not having symptoms, treatment of the fluid itself isn’t usually recommended. But most people are symptomatic, and the initial step is draining the fluid with a needle to see how much your breathing improves.
When fluid keeps coming back, there are two main strategies to manage it long-term.
Chemical Pleurodesis
This procedure seals the space around the lung so fluid can’t re-accumulate. A substance (usually talc) is introduced into the pleural space, triggering inflammation that fuses the two layers of the lung lining together. It requires a hospital stay of about 2 to 4 days. The fluid returns in 10% to 40% of cases, and about 22% of patients end up needing an additional procedure afterward. It works best when the lung can still fully expand.
Indwelling Pleural Catheter
This is a thin, flexible tube that stays in your chest and lets you (or a caregiver) drain fluid at home, typically every few days. There’s no hospital stay required for the placement. About 45% of people who get one experience spontaneous sealing of the pleural space after an average of 52 days, meaning the catheter can eventually be removed. The tradeoff is a higher rate of minor complications: about 36% of patients experience issues like skin infections around the catheter site or catheter blockages, though these are generally manageable with oral antibiotics. Only 6% need a follow-up surgical procedure.
For people with trapped lung, where the lung can’t fully re-expand, a catheter is the preferred option since pleurodesis can’t work without the two layers of the lung lining coming into contact.
Prognosis After Diagnosis
Median survival after a malignant pleural effusion is diagnosed ranges from 4 to 9 months, though this varies considerably by cancer type, overall health, and how well the underlying cancer responds to treatment. Certain factors predict a shorter timeline: patients with elevated white blood cell counts, low blood protein levels, and low oxygen levels together had a median survival of just 42 days in one study of 298 patients. These numbers reflect historical averages, and newer targeted therapies and immunotherapies for some cancers may shift outcomes for certain patients.